HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 278, Issue 38, 35923-35930, September 19, 2003

This Article Full Text Full Text (PDF) All Versions of this Article: 278/38/35923    most recent M304978200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Johanson, K. Articles by Hyman, L. E. Search for Related Content PubMed PubMed Citation Articles by Johanson, K. Articles by Hyman, L. E. Social Bookmarking                      What's this?

GRS1, a Yeast tRNA Synthetase with a Role in mRNA 3' End Formation^*

Kelly Johanson, Tina Hoang, Mehul Sheth and Linda E. Hyman 

From the Department of Biochemistry, Tulane University Health Sciences Center, New Orleans, Louisiana 70112

Transcription termination and 3' end formation are essential processes necessary for gene expression. However, the specific mechanisms responsible for these events remain elusive. A screen designed to identify trans-acting factors involved in these mechanisms in Saccharomyces cerevisiae identified a temperature-sensitive mutant that displayed phenotypes consistent with a role in transcription termination. The complementing gene was identified as GRS1, which encodes the S. cerevisiae glycyl-tRNA synthetase. This result, although unusual, is not unprecedented given that the involvement of tRNA synthetases in a variety of cellular processes other than translation has been well established. A direct role for the synthetase in transcription termination was determined through several in vitro assays using purified wild type and mutant enzyme. First, binding to two well characterized yeast mRNA 3' ends was demonstrated by cross-linking studies. In addition, it was found that all three substrates compete with each other for binding to GlyRS enzyme. Next, the affinity of the synthetase for the two mRNA 3' ends was found to be similar to that of its "natural" substrate, glycine tRNA in a nitrocellulose filter binding assay. The effect of the grs1-1 mutation was also examined and found to significantly reduce the affinity of the enzyme for the three RNA substrates. Taken together, these data indicate that not only does this synthetase interact with several different RNA substrates, but also that these substrates bind to the same site. These results establish a direct role for GRS1 in mRNA 3' end formation.

Received for publication, May 12, 2003 , and in revised form, June 23, 2003.

^* This work was supported by National Science Foundation Grant 9975758 and by Board of Regents Support Fund (to K. J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Dept. of Biochemistry SL43, Tulane University Health Sciences Center, 1430 Tulane Ave., New Orleans, LA 70112. Tel.: 504-584-2941; Fax: 504-584-2739; E-mail: lhyman{at}tulane.edu.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				P. A. James, M. Z. Cader, F. Muntoni, A. -M. Childs, Y. J. Crow, and K. Talbot Severe childhood SMA and axonal CMT due to anticodon binding domain mutations in the GARS gene. Neurology, November 14, 2006; 67(9): 1710 - 1712. [Abstract] [Full Text] [PDF]